Cargando…
Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies
Hepatocellular carcinoma (HCC) is one of the most common and lethal malignant tumors worldwide. HCC is a complex process that is associated with several etiological factors, which in turn result in aberrant activation of different cellular and molecular pathways and the disruption of balance between...
Autores principales: | Alqahtani, Ali, Khan, Zubair, Alloghbi, Abdurahman, S. Said Ahmed, Tamer, Ashraf, Mushtaq, M. Hammouda, Danae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780754/ https://www.ncbi.nlm.nih.gov/pubmed/31450841 http://dx.doi.org/10.3390/medicina55090526 |
Ejemplares similares
-
Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy
por: Alqahtani, Ali, et al.
Publicado: (2019) -
Trastuzumab Deruxtecan-Induced Interstitial Lung Disease/Pneumonitis in ERBB2-Positive Advanced Solid Malignancies: A Systematic Review
por: Abuhelwa, Ziad, et al.
Publicado: (2022) -
Anti‐PD‐1 therapy using cemiplimab for advanced cutaneous squamous cell carcinoma in HIV patient: A case report
por: Alloghbi, Abdurahman, et al.
Publicado: (2021) -
NTRK3 mutation in secretory carcinoma of the parotid gland: A Case report
por: AlKaabba, Fahad, et al.
Publicado: (2022) -
A Case of a False-Positive Urine Pregnancy Test and Delayed Diagnosis of Obstructive Pyelonephritis
por: Mital, Rahul, et al.
Publicado: (2020)